The Adeno-Associated Virus Gene Therapy Market was valued at approximately ~USD 2000 Million in 2023 and is expected to grow at a strong CAGR of around 39% during the forecast period (2024-2032) Several pharmaceutical companies is rapidly investing in research and development, thus driving the market growth during the forthcoming years. The high cost associated with the AAV gene therapy is one...